文献速递其他结缔组织病

原发性干燥综合征患者对病毒抗原产生增强的免疫应答

Viral antigens elicit augmented immune responses in primary Sjögren's syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究对未经治疗的原发性干燥综合征(pSS)患者、羟氯喹治疗的pSS患者及健康对照进行裂解流感病毒疫苗纵向接种观察,发现未治疗pSS患者疫苗特异性IgG滴度更高,抗Ro52自身抗体滴度升高,单核细胞NEMO/IKBKG基因表达差异与疫苗血清学应答相关,提示pSS对病毒抗原暴露存在增强的固有和适应性免疫应答。

要点

  • 未治疗pSS患者疫苗接种后特异性IgG滴度高于健康对照。
  • 未治疗pSS患者抗Ro52自身抗体滴度升高,羟氯喹治疗者不变。
  • 单核细胞NEMO/IKBKG基因高表达与更强疫苗血清学应答相关。

核心结论

  • pSS患者对病毒抗原暴露表现出增强的固有和适应性免疫应答,提示对免疫挑战存在过度反应,支持感染驱动免疫病理并作为pSS环境风险因素。

研究设计与样本

  • 纵向随访未治疗pSS患者(n=17)、羟氯喹治疗pSS患者(n=8)和健康对照(n=16)在裂解流感病毒疫苗接种期间的细胞、转录组和血清学应答。

主要发现

  • 未治疗pSS患者疫苗特异性IgG滴度高于对照。
  • 未治疗pSS患者抗Ro52自身抗体滴度升高,羟氯喹治疗者不变。
  • 未观察到包括EULAR干燥综合征患者报告指数评分在内的疾病症状变化。
  • 单核细胞转录组分析显示NEMO/IKBKG基因疫苗接种相关差异表达,未治疗pSS患者中更高诱导表达与更高血清学疫苗应答相关。

临床怎么用

  • pSS患者接种病毒疫苗后可能产生增强的体液免疫应答,但需关注自身抗体滴度变化。

局限性

  • 样本量较小(未治疗pSS 17例、羟氯喹治疗pSS 8例、对照16例),结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Infections have been suggested in the pathogenesis of primary SS (pSS). Systematic studies of immune responses to microbial antigens in vivo may be performed during vaccination. In the present study, we therefore longitudinally followed patients with pSS and controls during split-virion influenza vaccination to identify pSS-specific cellular, transcriptomic and serological responses. METHODS: Patients without treatment (pSSUntr, n = 17), on hydroxychloroquine-treatment (pSSHCQ, n = 8), and healthy controls (n = 16) were included. Antibody titres were determined by ELISA. Plasma proteins were measured by proximity extension assay. Monocyte gene expression was assessed by Nanostring. Routine laboratory tests were performed and clinical disease symptoms were registered by questionnaires. RESULTS: pSSUntr developed higher vaccine-specific IgG titres compared with controls. Notably, anti-Ro52 autoantibody titres increased in pSSUntr but remained unchanged in pSSHCQ. No changes in disease symptoms including EULAR Sjögren's Syndrome Patient Reported Index score were registered. Twenty-four hours after vaccination, the leucocyte count in pSSUntr decreased, with a concomitant increase of CCL7 in plasma. Transcriptomic analysis in monocytes revealed differential vaccination-related expression of the NEMO/IKBKG gene, and its higher induced expression in pSSUntr associated with higher serological vaccine responses. Moreover, titres of vaccine-specific antibodies were associated with higher vaccination-induced NF-κB signalling and higher steady-state IFN signatures in monocytes, and with the levels of several plasma proteins with soluble PD-1 displaying the strongest association. CONCLUSION: We observed augmented innate and adaptive immune responses in pSS following viral antigen exposure suggesting an underlying hyper-responsiveness to immune challenges, supporting a role for infections driving the immunopathology and acting as environmental risk factor for pSS.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Björk A, Thorlacius GE, Mofors J, et al. Viral antigens elicit augmented immune responses in primary Sjögren's syndrome. Rheumatology (Oxford). 2020. PMID: 31665501. doi:10.1093/rheumatology/kez509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。